Skip to main content
. 2014 Apr 4;28(9):1811–1818. doi: 10.1038/leu.2014.100

Figure 4.

Figure 4

Immunostaining of bone marrow biopsies with the anti-wild-type calreticulin antibody. Representative sections from CALR-unmutated ET/PMF patients (JAK2V617F mutated, MPLW515L mutated and triple-negative mutation) and from CALR-mutated patients (CALRdel52, CALRins5 and CALRindel) are shown in panel a and panel b, respectively.